DK1121109T3 - Tofaset sammensætning med tramadol - Google Patents
Tofaset sammensætning med tramadolInfo
- Publication number
- DK1121109T3 DK1121109T3 DK99953856T DK99953856T DK1121109T3 DK 1121109 T3 DK1121109 T3 DK 1121109T3 DK 99953856 T DK99953856 T DK 99953856T DK 99953856 T DK99953856 T DK 99953856T DK 1121109 T3 DK1121109 T3 DK 1121109T3
- Authority
- DK
- Denmark
- Prior art keywords
- active substance
- weight
- tramadol
- phase composition
- release rate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title 1
- 229960004380 tramadol Drugs 0.000 title 1
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 4
- 238000000338 in vitro Methods 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000014 opioid analgesic Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE29818454U DE29818454U1 (de) | 1998-10-15 | 1998-10-15 | Opioid-Analgetikum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1121109T3 true DK1121109T3 (da) | 2006-10-02 |
Family
ID=8063985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99953856T DK1121109T3 (da) | 1998-10-15 | 1999-10-15 | Tofaset sammensætning med tramadol |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1121109B8 (da) |
| JP (1) | JP5414956B2 (da) |
| AT (1) | ATE327742T1 (da) |
| AU (1) | AU1039400A (da) |
| CY (1) | CY1105168T1 (da) |
| DE (2) | DE29818454U1 (da) |
| DK (1) | DK1121109T3 (da) |
| ES (1) | ES2267301T3 (da) |
| PT (1) | PT1121109E (da) |
| WO (1) | WO2000021520A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| US9820982B2 (en) | 2001-07-06 | 2017-11-21 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| BR0210855A (pt) | 2001-07-06 | 2006-10-24 | Penwest Pharmaceuticals Compan | Método de fabricação de formulações de liberação prolongada |
| CA2478515C (en) | 2002-04-05 | 2010-09-28 | Purdue Pharma | Pharmaceutical preparation containing oxycodone and naloxone |
| JP2006328053A (ja) * | 2005-04-26 | 2006-12-07 | Takeda Chem Ind Ltd | モルヒネ含有医薬 |
| EP2002828B1 (en) | 2006-03-30 | 2019-08-07 | Nippon Zoki Pharmaceutical Co. Ltd. | Solid pharmaceutical preparation |
| JP2011511782A (ja) | 2008-02-12 | 2011-04-14 | アボット・ラボラトリーズ | 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途 |
| EP2555756B1 (en) * | 2010-04-07 | 2018-08-22 | Lupin Limited | Controlled release pharmaceutical compositions of tapentadol |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ260408A (en) * | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
| IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| US5395626A (en) * | 1994-03-23 | 1995-03-07 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
| US5645858A (en) * | 1994-10-06 | 1997-07-08 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
| KR100341829B1 (ko) * | 1996-03-08 | 2002-08-22 | 니코메드 덴마크 에이/에스 | 방출특성이변형된다-유니트투여량조성물 |
| DE19710008A1 (de) * | 1997-03-12 | 1998-09-17 | Basf Ag | Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung |
-
1998
- 1998-10-15 DE DE29818454U patent/DE29818454U1/de not_active Expired - Lifetime
-
1999
- 1999-10-15 AU AU10394/00A patent/AU1039400A/en not_active Abandoned
- 1999-10-15 PT PT99953856T patent/PT1121109E/pt unknown
- 1999-10-15 JP JP2000575496A patent/JP5414956B2/ja not_active Expired - Fee Related
- 1999-10-15 WO PCT/EP1999/007842 patent/WO2000021520A2/de not_active Ceased
- 1999-10-15 AT AT99953856T patent/ATE327742T1/de active
- 1999-10-15 ES ES99953856T patent/ES2267301T3/es not_active Expired - Lifetime
- 1999-10-15 DE DE59913493T patent/DE59913493D1/de not_active Expired - Lifetime
- 1999-10-15 EP EP99953856A patent/EP1121109B8/de not_active Expired - Lifetime
- 1999-10-15 DK DK99953856T patent/DK1121109T3/da active
-
2006
- 2006-08-23 CY CY20061101186T patent/CY1105168T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000021520A2 (de) | 2000-04-20 |
| DE29818454U1 (de) | 1999-01-14 |
| WO2000021520A3 (de) | 2000-08-03 |
| PT1121109E (pt) | 2006-09-29 |
| CY1105168T1 (el) | 2010-03-03 |
| EP1121109A2 (de) | 2001-08-08 |
| DE59913493D1 (de) | 2006-07-06 |
| EP1121109B1 (de) | 2006-05-31 |
| JP2002527384A (ja) | 2002-08-27 |
| ES2267301T3 (es) | 2007-03-01 |
| ATE327742T1 (de) | 2006-06-15 |
| JP5414956B2 (ja) | 2014-02-12 |
| EP1121109B8 (de) | 2006-07-19 |
| AU1039400A (en) | 2000-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003072025A3 (en) | Modified release formulations of at least one form of tramadol | |
| AP1526A (en) | Sertraline salts and sustained-release dosage forms of sertraline. | |
| WO2001085257A3 (en) | Opioid antagonist compositions and dosage forms | |
| BR9908545A (pt) | Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica | |
| ES2058111T3 (es) | Composicion de liberacion controlada de dihidrocodeina. | |
| BR9916790A (pt) | Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente | |
| NO20022264L (no) | Farmasoytisk blanding inneholdende tolterodin, samt anvendelse derav | |
| CA2339991A1 (en) | Microemulsions as solid dosage forms for oral administration | |
| MY127797A (en) | 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient | |
| TR200100889T2 (tr) | Disfosfonik asit içeren terkipler | |
| AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| SG162605A1 (en) | Pharmaceutical compositions | |
| ATE327742T1 (de) | Zweiphasige zusammensetzung mit tramadol | |
| CA2415154A1 (en) | Modified release formulations of selective serotonin re-uptake inhibitors | |
| BR0207297A (pt) | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo | |
| WO2001051055A3 (en) | Pharmaceutical compositions containing steroidal structures and uses thereof | |
| CA2348395A1 (en) | Compositions comprising a mixture of bioflavonols | |
| WO2004096181A3 (en) | Solid dosage form comprising desmopressin | |
| ZA202404160B (en) | Oral solution containing lisdexamfetamine and process for the preparation thereof | |
| YU20050411A (sh) | Komopzicije oksikodona sa kontrolisanim oslobadanjem | |
| WO2002081462A8 (en) | Aminoflavone compounds, compositions, and methods of use thereof | |
| AP2002002662A0 (en) | Sertraline salts and sustained-release dosage forms of sertraline | |
| YU20050409A (sh) | Kompozicije oksikodona sa kontrolisanim oslobađanjem | |
| SE0000782D0 (sv) | Pharmaceutical formulation and its use | |
| TH20304A (th) | สูตรปลดปล่อยที่ควบคุมซึ่งมีทรามาดอล |